Point of Care Molecular Diagnostics Market |Expected to reach USD 1440.2 Million by 2023|at a CAGR of 14.7%

Point of Care Molecular Diagnostics Market is expected to reach USD 1440.2 Million by 2023 from USD 725.5 Million in 2018, at a CAGR of 14.7%. Growth in the point-of-care (POC) molecular diagnostics market is mainly driven by factors such as the increasing worldwide prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests.

Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=143524127

Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) – Global Forecast to 2023", published by MarketsandMarkets™

Scope of the Report

The research report categorizes the global POC molecular diagnostics market into the following segments and subsegments:

POC molecular Diagnostics Market, by Product & Service
Assays & Kits
Instruments/Analyzers
Services & Software

POC Molecular Diagnostics Market, by Application
Respiratory diseases
STDs
HAIs
Oncology
Hepatitis
Other Applications

POC Molecular Diagnostics Market, by Technology
RT-PCR
INAAT
Others Technologies
POC Molecular Diagnostics Market, by End User
Physician Offices
Hospital Emergency Departments & Intensive Care Units
Research Institutes
Other End User

POC Molecular Diagnostics Market, by Region
North America
US
Canada
Europe
Asia Pacific
Rest of the World (RoW)

To Know More @ https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html